Real-world effectiveness and safety of ritlecitinib in adolescents with severe alopecia areata: A 36-week single-center study.
- DOI
- 10.1016/j.jaad.2026.07.009
- Published
- 2026 Jul 7
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2026.07.009,
title = {Real-world effectiveness and safety of ritlecitinib in adolescents with severe alopecia areata: A 36-week single-center study.},
author = {Starace M and Cedirian S and Pampaloni F and Rapparini L and Quadrelli F and Bruni F and Martelli G and Piraccini BM},
year = {2026},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2026.07.009},
url = {https://doi.org/10.1016/j.jaad.2026.07.009}
}RIS
TY - JOUR TI - Real-world effectiveness and safety of ritlecitinib in adolescents with severe alopecia areata: A 36-week single-center study. AU - Starace M AU - Cedirian S AU - Pampaloni F AU - Rapparini L AU - Quadrelli F AU - Bruni F AU - Martelli G AU - Piraccini BM PY - 2026 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2026.07.009 UR - https://doi.org/10.1016/j.jaad.2026.07.009 ER -
APA
M, S., S, C., F, P., L, R., F, Q., F, B., G, M., & BM, P. (2026). Real-world effectiveness and safety of ritlecitinib in adolescents with severe alopecia areata: A 36-week single-center study.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.07.009
Source records
- pubmed · retrieved 2026-09-26T23:32:09.614Z